Advances in Hematological Malignancies
Recent decades have witnessed remarkable strides in the area of hematological malignancies. Novel treatment modalities such as targeted agents, immunotherapies, and gene editing are transforming the survival rates for patients with blood cancers. Clinical trials continue to explore these innovative techniques, offering hope for more effective treat